Owlstone Medical has developed a breathalyzer for disease.
Every time you breath out there are hundreds of chemicals on your breath; some are telltale markers of disease, which our microchip chemical sensor technology is able to detect.
Our vision is to change the way we currently diagnose and monitor serious disease; we aim to be become the global leader in the non-invasive detection of cancer, infectious disease and inflammatory disease.
They key is detecting diseases earlier, when treatments are more effective, where more lives can be saved. There is no better example than cancer, where if detected early the chances of survival can be as good at 95% but at late stage it drops to about 5% - unfortunately there are still far too many people detected at late stage.
Through early detection we have set ourselves a goal that by 2020 we will have saved 100,000 lives and $1.5B in health care costs.